Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 9, 2010, Pages 1212-1221

  Pulsipher, Michael A ^a   Horwitz, Edwin M ^b   Haight, Ann E ^c   Kadota, Richard ^d   Chen, Allen R ^e   Frangoul, Haydar ^f   Cooper, Laurence J N ^g   Jacobsohn, David A ^h   Goyal, Rakesh K ⁱ   Mitchell, David ^j   Nieder, Michael L ^k   Yanik, Gregory ^l   Cowan, Morton J ^m   Soni, Sandeep ⁿ   Gardner, Sharon ^o   Shenoy, Shalini ^p   Taylor, Douglas ^q   Cairo, Mitchell ^r   Schultz, Kirk R ^s  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h CHILDREN'S MEMORIAL HOSPITAL   (United States)

ⁱ CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^j MONTREAL CHILDREN S HOSPITAL   (Canada)

^k JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^l UNIVERSITY OF MICHIGAN   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ NATIONWIDE CHILDREN S HOSPITAL   (United States)

^o NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^p WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r Columbia Presbyterian College of Physicians and Surgeons ^*  (United States)

^s UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Cooperative Group Studies; Hematopoietic Stem Cell Transplantation; Pediatrics; Transplantation of Non malignant Disorders

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; GLUTAMINE; IMMUNOSUPPRESSIVE AGENT; PALIFERMIN; PROTEIN TYROSINE KINASE INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOTRANSPLANTATION; APLASTIC ANEMIA; BACTERIAL INFECTION; BK VIRUS; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHILDHOOD DISEASE; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOSUPPRESSIVE TREATMENT; MUCOSA INFLAMMATION; MYCOSIS; NORTH AMERICA; POLYOMAVIRUS INFECTION; REDUCED INTENSITY CONDITIONING; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SICKLE CELL ANEMIA; THALASSEMIA; UMBILICAL CORD BLOOD;

EID: 77955509680     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.12.536     Document Type: Review

References (31)

1. Baker K.S., Filipovich A.H., Gross T.G., et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008, 42:175-180.
2. Bhatia M., Walters M.C. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 2008, 41:109-117.
3. Iannone R., Casella J.F., Fuchs E.J., et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003, 9:519-528.
4. Shenoy S., Grossman W.J., DiPersio J., et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005, 35:345-352.
5. Griffith L.M., Cowan M.J., Kohn D.B., et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol 2008, 122:1087-1096.
6. Dvorak C.C., Cowan M.J. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant 2008, 41:119-126.
7. Duffner P.K., Caggana M., Orsini J.J., et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol 2009, 40:245-252.
8. Yoshimi A., Kojima S., Taniguchi S., et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008, 14:1057-1063.
9. Chan K.W., McDonald L., Lim D., et al. Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant 2008, 42:589-595.
10. Bader P., Kreyenberg H., Henze G.H., et al. Prognostic value of minimal residual disease quantification before allogeneic stem cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol 2009, 27:377-384.
11. Uzunel M., Mattsson J., Jaksch M., et al. The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia. Blood 2001, 98:1982-1984.
12. Pulsipher M.A., Boucher K.M., Wall D., et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009, 114:1429-1436.
13. Pulsipher M.A., Bader P., Klingebiel T., et al. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Biol Blood Marrow Transplant 2008, 15:62-71.
14. Frangoul H., Nemecek E.R., Billheimer D., et al. A prospective study of G-CSF- primed bone marrow as a stem cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood 2007, 110:4584-4587.
15. Grupp S.A., Verneris M., Sondel P.M., et al. Immunotherapy for pediatric cancer. Biol Blood Marrow Transplant 2008, 14:33-43.
16. Cooper L.J. Adoptive cellular immunotherapy for childhood malignancies. Bone Marrow Transplant 2008, 41:183-192.
17. Jacobsohn D.A. Acute graft-versus-host disease in children. Bone Marrow Transplant 2008, 41:215-221.
18. Lee S.J., Zahrieh D., Agura E., et al. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood 2004, 104:1559-1564.
19. Goyal R.K., Fairfull L., Livote E., et al. TNF-α and TNF receptor superfamily member 1B polymorphisms predict risk of acute GVHD following matched unrelated donor BMT in children. Biol Blood Marrow Transplant 2008, 14:24.
20. Jacobsohn D.A., Gilman A.L., Rademaker A., et al. Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Blood 2009, 114:4354-4360.
21. Aquino V.M., Harvey A.R., Garvin J.H., et al. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 2005, 36:611-616.
22. Sanders J.E., Im H.J., Hoffmeister P.A., et al. Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood 2005, 105:3749-3756.
23. Phipps S., Dunavant M., Srivastava D.K., et al. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000, 18:1004-1011.
24. Phipps S., Rai S.N., Leung W.H., et al. Cognitive and academic consequences of stem cell transplantation in children. J Clin Oncol 2008, 26:2027-2033.
25. Eapen M., Raetz E., Zhang M.J., et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006, 107:4961-4967.
26. Sanders J.E. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant 2004, 8(Suppl 5):39-50.
27. Howard D.S., Phillips I.G., Reece D.E., et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999, 29:1494-1501.
28. La Rosa A.M., Champlin R.E., Mirza N., et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001, 32:871-876.
29. Neofytos D., Ojha A., Mookerjee B., et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007, 13:74-81.
30. Kampmann B., Cubitt D., Walls T., et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005, 130:595-603.
31. Toth K., Spencer J.F., Dhar D., et al. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc Natl Acad Sci USA 2008, 105:7293-7297.